Celestica Inc. (NYSE:CLS) Insider Alok K. Agrawal Sells 6,826 Shares

Celestica Inc. (NYSE:CLSGet Free Report) (TSE:CLS) insider Alok K. Agrawal sold 6,826 shares of the firm’s stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $133.92, for a total value of $914,137.92. Following the sale, the insider now directly owns 9,224 shares in the company, valued at $1,235,278.08. The trade was a 42.53 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Celestica Stock Up 8.8 %

Shares of NYSE:CLS traded up $11.55 during midday trading on Wednesday, reaching $143.53. The company had a trading volume of 8,448,756 shares, compared to its average volume of 5,105,531. The business’s 50 day moving average price is $100.10 and its 200 day moving average price is $73.34. Celestica Inc. has a 1-year low of $35.56 and a 1-year high of $144.27. The company has a quick ratio of 0.87, a current ratio of 1.47 and a debt-to-equity ratio of 0.49. The stock has a market cap of $16.70 billion, a PE ratio of 38.38 and a beta of 2.27.

Analysts Set New Price Targets

A number of research firms have recently commented on CLS. Canaccord Genuity Group raised their price target on Celestica from $77.00 to $110.00 and gave the stock a “buy” rating in a research report on Friday, December 20th. Cibc World Mkts upgraded shares of Celestica from a “hold” rating to a “strong-buy” rating in a report on Friday, January 31st. TD Cowen upped their price target on shares of Celestica from $68.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 24th. CIBC upgraded shares of Celestica from a “neutral” rating to a “sector outperform” rating and set a $150.00 price objective on the stock in a report on Friday, January 31st. Finally, Stifel Nicolaus assumed coverage on shares of Celestica in a research note on Tuesday. They issued a “buy” rating and a $140.00 target price for the company. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Celestica presently has an average rating of “Moderate Buy” and a consensus target price of $103.27.

Read Our Latest Research Report on CLS

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Peregrine Capital Management LLC bought a new position in shares of Celestica in the fourth quarter valued at $30,000. Optimum Investment Advisors raised its holdings in shares of Celestica by 66.7% in the 3rd quarter. Optimum Investment Advisors now owns 500 shares of the technology company’s stock valued at $26,000 after purchasing an additional 200 shares during the period. R Squared Ltd acquired a new stake in Celestica in the 4th quarter valued at about $51,000. Financial Management Professionals Inc. bought a new position in Celestica during the third quarter worth about $30,000. Finally, UMB Bank n.a. acquired a new position in Celestica during the third quarter worth approximately $34,000. Institutional investors and hedge funds own 67.38% of the company’s stock.

About Celestica

(Get Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

Further Reading

Insider Buying and Selling by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.